Biological Valve Prosthesis in Aortic Stenosis - Imaging, Biomarkers, Physical Performance and Patient Related Factors Predictive to Long-term Outcome (Bio-AS)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Patients with severe aortic stenosis accepted for transcatheter intervention or open surgery are included before the intervention, and then followed up with clinical visits during the first year after intervention. Imaging with echocardiography and computed tomography (CT) are performed together with additional imaging with magnetic resonance imaging (MRI) and Positron emissions tomography (PET)-CT in a subgroup of the study population. Blood samples, physical performance and questionnaires with focus on frailty and heart failure are also collected at each visit. A follow up with information of the outcomes after 2-5 years will be performed through national registries.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Accepted for aortic valve intervention

Locations
Other Locations
Sweden
Department of cardiology Uppsala University Hospital
RECRUITING
Uppsala
Contact Information
Primary
Christina Christersson, MD PhD
christina.christersson@medsci.uu.se
+46186119068
Time Frame
Start Date: 2019-05-15
Estimated Completion Date: 2027-12
Participants
Target number of participants: 300
Treatments
Preserved heart function
The group will be defined as preserved left ventricular ejection fraction (LVEF) with and without hypertrophy and with and without reduced global longitudinal strain (GLS).
Reduced heart function
The group will be defined as reduced LVEF
Related Therapeutic Areas
Sponsors
Leads: Uppsala University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials